Diabetes and Kidney Disease

This course will a comprehensive review of the management of diabetic kidney disease (DKD), including discussions of blood pressure control, new biomarkers and hypoglycemia agents on DKD development and progression.

Target Audience

Nephrologists, Emergency Medicine Physicians, Family Medicine Physicians, Internists, Hospitalists, Endocrinologists, Respiratory Therapists, Nurses, Nurse Practitioners and other interested healthcare professionals

Learning Objectives

• Summarize the guidelines for screening and management of diabetic kidney disease (DKD).
• Explain the contribution of blood pressure control with different agents on DKD development and progression.
• Describe how new biomarkers can help to stratify patients.
• Summarize the contribution of different hypoglycemia agents on DKD development and progression.

Additional information
Bibliography: 
  • Williams, J. K. Y. (2017). Management Strategies for Patients with Diabetic Kidney Disease and Chronic Kidney Disease in Diabetes. Nursing Clinics, 52(4), 575-587.

Available Topics

Nephrology Online Series (Multiple Modules)

This online series includes timely content relevant to the treatment of nephrology patients. Please visit us often as we continue to build this online nephrology medicine library.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 General certificate of attendance
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Nursing
  • 1.00 Florida Board of Respiratory Therapy
Course opens: 
03/01/2018
Course expires: 
02/28/2023

Alessia Fornoni, M.D., Ph.D.
Professor of Medicine
Chief, Katz Family Division of Nephrology and Hypertension
Director, Peggy and Harold Katz Family Drug Discovery Center
University of Miami
Miami, Florida

Alessia Fornoni, M.D., Ph.D., indicated that she has relevant financial relationships and she will not include off-label or unapproved product usage in her presentation or discussion.
Grant/Research Support: Roche, Boehringer Ingelheim
Consultant: Variant Pharmaceutical, Ono, Pfeizer, Boehringer Ingelheim, AstraZeneca, Roche, Merck and Johnson and Johnson.
Stock Shareholder: Variant Pharmaceuticals

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
             
Baptist Health South Florida designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 General certificate of attendance
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Nursing
  • 1.00 Florida Board of Respiratory Therapy
Please login or register to take this course.

Required Hardware/software

PC/Mac Users
PC/Mac Users

This site is supported on the most recent stable releases of the following browsers:

Click Here to Download Google Chrome
Google Chrome		Microsoft Edge
Microsoft Edge		Safari
Safari		Moxilla Firefox
Mozilla Firefox
Internet Explorer

Attention: Internet Explorer Users
This site offers limited support for Internet Explorer 11 (IE11). When using IE11, you will be prompted to download course videos instead of viewing them in the browser. After the course video downloads, the recordings will play.

Mobile Users
Mobile Users

This site is supported on the following mobile devices:

  • Apple iOS mobile devices running iOS 10 or later
  • Android mobile devices running Android 4.4 or later, with the latest release of Google Chrome or Mozilla Firefox
Technical Support
Technical Support

If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.